Understanding blood flow regulation in health and disease
Official title: Vascular Function in Health & Disease: Rehabilitation for Hypertension; Exercise and Skeletal Muscle Afferent Feedback
Run by University of Utah · NCT02966665 · Data updated 2026-11-12
This study is trying to understand how blood flow to muscles works in healthy people and those with conditions like COPD and heart failure, especially during exercise.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 420 (estimated) |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Status | Recruiting |
| Started | September 2008 |
| Main results expected | August 2030 |
| Study ends | August 2030 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT02966665 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy young adults, older adults, and patients diagnosed with COPD, pulmonary arterial hypertension, heart failure, or hypertension.
✕Probably not a fit
Patients with severe COPD or a history of myocardial infarction may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the mechanisms that regulate blood flow to muscle tissues, particularly focusing on the role of the renin-angiotensin system and nitric oxide in vascular function. It aims to understand how aging and various diseases, such as COPD and heart failure, affect vascular tone and perfusion during exercise. The study involves maximum exercise tests and various interventions to assess their impact on vascular health and function. By comparing healthy young and older volunteers with patients suffering from chronic conditions, the research seeks to uncover the underlying factors contributing to vascular dysfunction.
Why it matters
Potential benefit: If successful, this study could lead to improved treatments for patients with vascular dysfunction, enhancing their physical activity capacity and overall cardiovascular health.
How similar studies have gone: While some studies have explored aspects of vascular function and the renin-angiotensin system, this specific approach appears to be novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy Young Volunteers: 18-30 years of age with no diseases or conditions that would affect their participation in the study * Healthy Older Controls: volunteers 65 years of age or older with no diseases or conditions that would affect their participation in the study * Coronary Angiography subjects: patients undergoing routine coronary angiography * Chronic Obstructive Pulmonary Disease subjects: patients diagnosed with mild to moderate COPD * Pulmonary Arterial Hypertension subjects: patients with idiopathic or heritable Group 1 pulmonary arterial hypertension * Heart Failure subjects: patients with Class I, II or III New York Heart Association symptoms of Heart Failure * Hypertension subjects: patients diagnosed with chronic high blood pressure Exclusion Criteria: * Severe COPD (use of supplemental oxygen, or have a one-second forced expiratory volume of less than 30% predicted) * History of myocardial infarction * History of percutaneous coronary revascularization * History of coronary artery bypass grafting * Unstable angina pectoris * History of variant angina * Ejection fraction \< 50% * Significant renal disease (Glomerular Filtration Rate \< 50 mL/min/1.73m2) * Subjects whose medical care or safety may be at risk from undergoing a Magnetic Resonance Imaging examination (e.g. pacemaker, metal implants, certain types of heart valves) * Subject is pregnant * Subject has physical ailments (other than COPD, PAH, HF, or hypertension) that would prevent them from study participation in the judgment of the investigator
Where it's running
-
University of Utah
Salt Lake City, Utah, United States Recruiting
Study contacts
- Principal investigator: David W Wray, Ph.D. — University of Utah
- Study coordinator: Jarred Iacovelli
- Email: jarred.iacovelli@utah.edu
- Phone: 801-581-7606
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Research on health inequality and genetic disparity in cardiovascular diseases
This study is trying to understand how health differences and genetics affect heart diseases in people from various ethnic backgrounds in the UK to help improve treatments for everyone.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Monitoring progression of chronic cardiovascular conditions
This project will collect wearable physiologic data from adults with cardiovascular conditions to see how their heart disease changes over time.
-
Pulmonary Artery Denervation for a specific type of heart and lung pressure problem
This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.
-
Managing multiple medications in older adults with chronic diseases
This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.
-
Village-based program to manage chronic heart conditions in Qujiang older adults
This project will try a village-based program combining medicines, lifestyle support, education, and 7-day ECG monitoring for people aged 60+ in Qujiang with chronic heart conditions such as atrial fibrillation, high blood pressure, coronary artery disease, or heart failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.